Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging

A low level of high-density lipoprotein cholesterol (HDL-C) is a risk factor for atherosclerotic disease. Magnetic resonance imaging (MRI) can provide detailed information on carotid atherosclerotic plaque size and composition. The purpose of this study was to correlate HDL levels with carotid plaque burden and composition by MRI. Thirty-four patients with coronary artery disease (CAD) receiving simvastatin plus niacin or placebo for both drugs for three years were randomly selected to undergo MRI of carotid arteries. Atherosclerotic plaque wall volumes (WVs) and plaque components including lipid rich/necrotic core (LR/NC), calcium, fibrous tissue, and loose matrix were measured. Mean WV or atherosclerotic burden was significantly associated with total HDL-C levels (r = −0.39, P = 0.02), HDL2 (r = −0.36, P = 0.03), HDL3 (r = −0.34, P = 0.04), and LDL/HDL ratio (r = 0.42, P = 0.02). Plaque lipid composition or LR/NC was significantly associated with HDL3 (r = −0.68, P = 0.02). Patients with low HDL levels (≤35 mg/dL) had increased WV (97 ± 23 vs. 81 ± 19 mm3, P = 0.05) compared with patients with HDL levels > 35 mg/dL. Among CAD patients, low HDL-C levels were significantly associated with increased carotid atherosclerotic plaque burden and lipid content by MRI.

[1]  C. Yuan,et al.  Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Jan Nilsson,et al.  Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I , 2001, Circulation.

[3]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[4]  V. Fuster,et al.  Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.

[5]  C Yuan,et al.  In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[6]  D. Tanné,et al.  High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. , 1997, Stroke.

[7]  Dominick J. Angiolillo,et al.  Imaging of atherosclerotic plaque , 2004, The International Journal of Cardiovascular Imaging.

[8]  W S Kerwin,et al.  Carotid Plaque Composition Differs Between Ethno-Racial Groups: An MRI Pilot Study Comparing Mainland Chinese and American Caucasian Patients , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[9]  C. Di Mario,et al.  Recombinant Apolipoprotein A-IMilano Infusion Into Rabbit Carotid Artery Rapidly Removes Lipid From Fatty Streaks , 2002, Circulation research.

[10]  S. Kaul,et al.  Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II , 2001, Circulation.

[11]  Chun Yuan,et al.  Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo , 1995, Nature Medicine.

[12]  Chun Yuan,et al.  Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging , 2002, Circulation.

[13]  Jenq-Neng Hwang,et al.  A Quantitative Vascular Analysis System for Evaluation of Atherosclerotic Lesions by MRI , 2001, MICCAI.

[14]  K R Maravilla,et al.  Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRI: A Case-Control Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Rouleau,et al.  Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease? , 2001, Circulation.

[16]  C Yuan,et al.  Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. , 1998, Circulation.

[17]  D. Spady.  Reverse cholesterol transport and atherosclerosis regression. , 1999, Circulation.

[18]  J. Albers,et al.  Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.

[19]  O. Joakimsen,et al.  Low Levels of High-Density Lipoprotein Cholesterol Are Associated With Echolucent Carotid Artery Plaques: The Tromsø Study , 2001, Stroke.

[20]  D. Gordon,et al.  High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .

[21]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[22]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[23]  C Yuan,et al.  Surface coil phased arrays for high‐resolution imaging of the carotid arteries , 1996, Journal of magnetic resonance imaging : JMRI.

[24]  G. Franceschini,et al.  Increased Carotid Artery Intima-Media Thickness in Subjects With Primary Hypoalphalipoproteinemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[25]  W. Kannel,et al.  High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. , 1983, The American journal of cardiology.

[26]  Loyd,et al.  SIMVASTATIN AND NIACIN , ANTIOXIDANT VITAMINS , OR THE COMBINATION FOR THE PREVENTION OF CORONARY DISEASE , 2001 .

[27]  V. Fuster,et al.  Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.